<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Orexigen Therapeutics, Inc. SEC Filings</title><link>http://ir.orexigen.com/Phoenix.zhtml?c=207034&amp;p=irol-sec</link><description>A Collection of Orexigen Therapeutics, Inc. SEC Filings</description><language>en-us</language><category>SEC: Insider Trading,SEC: 3,4,5,144,SEC: Current Reports,SEC: Annual Filings,SEC: Proxy Filings,SEC: Quarterly Filings</category><lastBuildDate>Tue, 21 May 2013 02:49:48 GMT</lastBuildDate><item><title>Form 10-Q</title><link>http://ir.orexigen.com/phoenix.zhtml?c=207034&amp;p=RssLanding&amp;cat=sec&amp;id=8808389</link><description><![CDATA[Quarterly report which provides a continuing view of a company's financial position]]></description><category>SEC: Quarterly Filings</category><guid isPermaLink="false">8808389_SEC</guid><pubDate>Thu, 09 May 2013 18:17:53 GMT</pubDate></item><item><title>Form 8-K</title><link>http://ir.orexigen.com/phoenix.zhtml?c=207034&amp;p=RssLanding&amp;cat=sec&amp;id=8805542</link><description><![CDATA[Report of unscheduled material events or corporate event]]></description><category>SEC: Current Reports</category><guid isPermaLink="false">8805542_SEC</guid><pubDate>Wed, 08 May 2013 20:07:13 GMT</pubDate></item><item><title>Form DEF 14A</title><link>http://ir.orexigen.com/phoenix.zhtml?c=207034&amp;p=RssLanding&amp;cat=sec&amp;id=8765743</link><description><![CDATA[Official notification to shareholders of matters to be brought to a vote ("Proxy")]]></description><category>SEC: Proxy Filings</category><guid isPermaLink="false">8765743_SEC</guid><pubDate>Tue, 23 Apr 2013 13:02:06 GMT</pubDate></item><item><title>Form 10-K</title><link>http://ir.orexigen.com/phoenix.zhtml?c=207034&amp;p=RssLanding&amp;cat=sec&amp;id=8698328</link><description><![CDATA[Annual report which provides a comprehensive overview of the company for the past year]]></description><category>SEC: Annual Filings</category><guid isPermaLink="false">8698328_SEC</guid><pubDate>Thu, 14 Mar 2013 21:22:02 GMT</pubDate></item><item><title>Form 8-K</title><link>http://ir.orexigen.com/phoenix.zhtml?c=207034&amp;p=RssLanding&amp;cat=sec&amp;id=8694916</link><description><![CDATA[Report of unscheduled material events or corporate event]]></description><category>SEC: Current Reports</category><guid isPermaLink="false">8694916_SEC</guid><pubDate>Wed, 13 Mar 2013 20:07:52 GMT</pubDate></item><item><title>Form 4</title><link>http://ir.orexigen.com/phoenix.zhtml?c=207034&amp;p=RssLanding&amp;cat=sec&amp;id=8693231</link><description><![CDATA[Statement of changes in beneficial ownership of securities]]></description><category>SEC: Insider Trading,SEC: 3,4,5,144</category><guid isPermaLink="false">8693231_SEC</guid><pubDate>Wed, 13 Mar 2013 00:27:07 GMT</pubDate></item><item><title>Form 4</title><link>http://ir.orexigen.com/phoenix.zhtml?c=207034&amp;p=RssLanding&amp;cat=sec&amp;id=8693231</link><description><![CDATA[Statement of changes in beneficial ownership of securities]]></description><category>SEC: Insider Trading,SEC: 3,4,5,144</category><guid isPermaLink="false">8693231_SEC</guid><pubDate>Wed, 13 Mar 2013 00:27:07 GMT</pubDate></item><item><title>Form 8-K</title><link>http://ir.orexigen.com/phoenix.zhtml?c=207034&amp;p=RssLanding&amp;cat=sec&amp;id=8640622</link><description><![CDATA[Report of unscheduled material events or corporate event]]></description><category>SEC: Current Reports</category><guid isPermaLink="false">8640622_SEC</guid><pubDate>Wed, 20 Feb 2013 11:04:00 GMT</pubDate></item><item><title>Form 4</title><link>http://ir.orexigen.com/phoenix.zhtml?c=207034&amp;p=RssLanding&amp;cat=sec&amp;id=8640473</link><description><![CDATA[Statement of changes in beneficial ownership of securities]]></description><category>SEC: Insider Trading,SEC: 3,4,5,144</category><guid isPermaLink="false">8640473_SEC</guid><pubDate>Wed, 20 Feb 2013 01:50:12 GMT</pubDate></item><item><title>Form 4</title><link>http://ir.orexigen.com/phoenix.zhtml?c=207034&amp;p=RssLanding&amp;cat=sec&amp;id=8640473</link><description><![CDATA[Statement of changes in beneficial ownership of securities]]></description><category>SEC: Insider Trading,SEC: 3,4,5,144</category><guid isPermaLink="false">8640473_SEC</guid><pubDate>Wed, 20 Feb 2013 01:50:12 GMT</pubDate></item></channel></rss>